Article Text
Editorial
Pirfenidone for IPF: pro/con debate; the ‘con’ viewpoint
Statistics from Altmetric.com
Footnotes
-
Contributors DRT and GR both contributed to the content of this article.
-
Competing interests None.
-
Provenance and peer review Not commissioned; internally peer reviewed.